Finish startup Algorithmiq and IBM to collaborate on quantum chemistry
Finish startup Algorithmiq and IBM join forces to explore ways to cut the time and cost of drug discovery and development.
The Finnish startup Algorithmiq establishes new cooperation with IBM focused on leveraging the power of quantum computing for drug discovery and development.
On average, it currently takes around a decade and US$1 billion for a new drug to get to market. Algorithmiq’s advances in this area are considered to reduce the time-to-market of new drugs significantly, and allow for more cost efficiency and better medical treatments.